You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康德萊醫械(01501.HK):HanchorValve臨牀試驗首例患者植入
格隆匯 11-24 07:53

格隆匯11月24日丨康德萊醫械(01501.HK)發佈公吿,公司子公司上海翰凌醫療器械有限公司研製的帶有錨定結構的球擴式經導管主動脈瓣膜置換(“TAVR”)產品HanchorValve已由復旦大學附屬中山醫院成功完成首例植入,該例手術也是全球首例帶有錨定結構的球擴式TAVR產品用於重度主動脈瓣關閉不全患者的瓣膜置換手術。

根據披露,HanchorValve是翰凌醫療首款擁有自主知識產權的TAVR產品,其獨特的錨定結構設計,可實現精準自主定位。這也是全球首款經股入路的既可治療重度主動脈瓣關閉不全又可治療重度主動脈瓣狹窄的球擴式TAVR產品。HanchorValve臨牀試驗首例患者植入的成功,標誌着由復旦大學附屬中山醫院作為主要研究中心的全國多箇中心臨牀試驗正式啟動。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account